Literature DB >> 12531348

Options for improvement of the Dutch measles vaccination schedule.

S van den Hof1, J Wallinga, M-A Widdowson, M A E Conyn-van Spaendonck.   

Abstract

We investigated which vaccination schedule gives best protection to the vaccinating population, in case of a measles epidemic in pockets of unvaccinated individuals. We explored the effect of an additional measles vaccination (at 6 or 9 months), advancing the first measles-mumps-rubella (MMR) vaccination from 14 to 11 months, and advancing the second MMR from 9 to 4 years. Measures of protection among vaccinees (percentage of susceptibles, number of reported cases, percentage of lifetime spent susceptible) were estimated with a mathematical model of the impact of antibody level on seroconversion and immunity. Advancing the age of second MMR vaccination prevents considerably more cases among vaccinees than an extra early measles vaccination or advancing the age of first MMR vaccination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531348     DOI: 10.1016/s0264-410x(02)00588-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands.

Authors:  L Mollema; G P Smits; G A Berbers; F R Van Der Klis; R S Van Binnendijk; H E De Melker; S J M Hahné
Journal:  Epidemiol Infect       Date:  2013-08-06       Impact factor: 4.434

2.  Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology.

Authors:  Tom Woudenberg; Rob S van Binnendijk; Elisabeth A M Sanders; Jacco Wallinga; Hester E de Melker; Wilhelmina L M Ruijs; Susan J M Hahné
Journal:  Euro Surveill       Date:  2017-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.